http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010507628-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-529 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010507628-A |
| titleOfInvention | Use of MTKI1 for the treatment or prevention of bone cancer |
| abstract | The present invention relates to a macrocyclic quinazoline derivative, 4,6-ethanediylidenepyrimido [4,5-b] [6,1,12] benzoxadiaza described as compound 22 in PCT publication WO 2004/105765. Cyclo-pentadecine, 17-bromo-8,9,10,11,12,13,14,19-octahydro-20-methoxy-13-methyl- is useful in the manufacture of a medicament for the treatment or prevention of bone cancer And methods for killing bone cancer cells including osteosarcoma, chondrosarcoma, myeloma bone disease and other osteolytic bone metastases from other primary sites. Accordingly, the present invention provides a method for treating, preventing, delaying or alleviating bone cancer or for preventing and treating bone loss associated with cancer metastasis. [Selection figure] None |
| priorityDate | 2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.